ES552336A0 - Un procedimiento para la preparacion de derivados de dihidropiridina - Google Patents

Un procedimiento para la preparacion de derivados de dihidropiridina

Info

Publication number
ES552336A0
ES552336A0 ES552336A ES552336A ES552336A0 ES 552336 A0 ES552336 A0 ES 552336A0 ES 552336 A ES552336 A ES 552336A ES 552336 A ES552336 A ES 552336A ES 552336 A0 ES552336 A0 ES 552336A0
Authority
ES
Spain
Prior art keywords
different
same
alkyl groups
group
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES552336A
Other languages
English (en)
Other versions
ES8704899A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of ES552336A0 publication Critical patent/ES552336A0/es
Publication of ES8704899A1 publication Critical patent/ES8704899A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES552336A 1984-06-28 1986-02-24 Un procedimiento para la preparacion de derivados de dihidropiridina Expired ES8704899A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59133650A JPS6112662A (ja) 1984-06-28 1984-06-28 ジヒドロピリジン誘導体及びその製法

Publications (2)

Publication Number Publication Date
ES552336A0 true ES552336A0 (es) 1987-04-16
ES8704899A1 ES8704899A1 (es) 1987-04-16

Family

ID=15109748

Family Applications (3)

Application Number Title Priority Date Filing Date
ES544647A Expired ES8707933A1 (es) 1984-06-28 1985-06-27 Un procedimiento para la preparacion de derivados de dihidropiridina.
ES552336A Expired ES8704899A1 (es) 1984-06-28 1986-02-24 Un procedimiento para la preparacion de derivados de dihidropiridina
ES552335A Expired ES8704898A1 (es) 1984-06-28 1986-02-24 Un procedimiento para la preparacion de derivados de dihidropiridina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES544647A Expired ES8707933A1 (es) 1984-06-28 1985-06-27 Un procedimiento para la preparacion de derivados de dihidropiridina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES552335A Expired ES8704898A1 (es) 1984-06-28 1986-02-24 Un procedimiento para la preparacion de derivados de dihidropiridina

Country Status (13)

Country Link
US (1) US4727082A (es)
EP (1) EP0167371B1 (es)
JP (1) JPS6112662A (es)
KR (1) KR900005019B1 (es)
AT (1) ATE61356T1 (es)
AU (1) AU569161B2 (es)
CA (2) CA1300157C (es)
DE (1) DE3581967D1 (es)
ES (3) ES8707933A1 (es)
GR (1) GR851568B (es)
MX (2) MX7533E (es)
PT (1) PT80714B (es)
SU (1) SU1342413A3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8503427D0 (en) * 1985-02-11 1985-03-13 Ici Plc Basic compounds
GB8503425D0 (en) * 1985-02-11 1985-03-13 Ici Plc Alkanolamine derivatives
EP0276552A1 (en) * 1986-12-08 1988-08-03 Yamanouchi Pharmaceutical Co. Ltd. 1,4-dihydropyridine derivatives and their production
US4843085A (en) * 1987-07-01 1989-06-27 Yamanouchi Pharmaceutical Co., Ltd. Pyridine derivatives, process for production thereof and pharmaceutical compositions useful as anti-arhytmics
GB9102031D0 (en) * 1991-01-30 1991-03-13 Fujisawa Pharmaceutical Co Dihydropyridine compounds,and process for their preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2753946A1 (de) * 1977-12-03 1979-06-13 Bayer Ag 1-n-aryl-1,4-dihydropyridine und ihre verwendung als arzneimittel
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
HU197881B (en) * 1982-08-06 1989-06-28 Banyu Pharma Co Ltd Process for producing new carbamoyl-oxy-alkyl-carboxy-lic acid derivatives
US4500527A (en) * 1983-06-22 1985-02-19 Usv Pharmaceutical Corporation Antihypertensive 4[(3-alkylamino-2-hydroxypropyl)-oxyiminomethyl phenyl]-1,4-dihydropyridines
NO854021L (no) * 1984-10-26 1986-04-28 Bayer Ag 1,4-dihydropyridin-hydroksyaminer og fremgangsmaate til fremstilling derav.
GB8503425D0 (en) * 1985-02-11 1985-03-13 Ici Plc Alkanolamine derivatives

Also Published As

Publication number Publication date
AU569161B2 (en) 1988-01-21
CA1312085C (en) 1992-12-29
ES544647A0 (es) 1987-09-01
JPS6112662A (ja) 1986-01-21
KR860000261A (ko) 1986-01-27
JPH0123463B2 (es) 1989-05-02
MX7533E (es) 1989-08-15
SU1342413A3 (ru) 1987-09-30
EP0167371A2 (en) 1986-01-08
GR851568B (es) 1985-11-25
KR900005019B1 (ko) 1990-07-18
AU4396785A (en) 1986-01-02
ES552335A0 (es) 1987-04-16
ATE61356T1 (de) 1991-03-15
EP0167371A3 (en) 1987-06-16
CA1300157C (en) 1992-05-05
MX26687A (es) 1994-03-31
PT80714A (en) 1985-07-01
ES8707933A1 (es) 1987-09-01
ES8704898A1 (es) 1987-04-16
EP0167371B1 (en) 1991-03-06
ES8704899A1 (es) 1987-04-16
DE3581967D1 (de) 1991-04-11
US4727082A (en) 1988-02-23
PT80714B (en) 1986-12-11

Similar Documents

Publication Publication Date Title
FI850140L (fi) Kemiska foereningar.
DE69514367D1 (de) Substituierte amidderivate
DK1031563T3 (da) Sulfonylderivater
BR9713417A (pt) Composto de açúcar, agente gelificante, composição de agente gelificante, processos para suas preparações e composição de gel.
FR2362921A1 (fr) Composition detergente a base d'alkyl- ou alcenyl-phosphates
EP0902007A4 (en) CHALCON DERIVATIVES AND MEDICINES THAT CONTAIN THEM
NO161564C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater.
EE04777B1 (et) Kasvajavastased ühendid, neid sisaldavad farmatseutilised kompositsioonid ning nende kasutamine
ES544647A0 (es) Un procedimiento para la preparacion de derivados de dihidropiridina.
FR2672801B1 (fr) Utilisation de derives de tetrahydrothienopyridine comme inhibiteurs de l'angiogenese.
ES2091489T3 (es) Derivados de imidazol y composiciones farmaceuticas que los contienen.
KR880002828A (ko) 디하이드로피리딘 유도체 및 이것의 약학적 조성말
NO159927C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aromatiske aminoacetylener.
AU557533B2 (en) Oxadithiadiaza, dioxaselenadiaza, dioxatelluradiaza, and dioxathiadiaza-2,5-pentalene derivatives
NO168580C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-furanethanaminer
RU94043812A (ru) Производные 1,4-дигидропиридина, смесь их изомеров или отдельные изомеры и их соли, 2-хлор-3-циано-бензальдегид и фармацевтическая композиция
NO166125C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aroyl-substituerte dihydro-1,4-tiaziner.
RU95102788A (ru) Производные бензоилхинолина, их кислотноаддитивные соли и комплексы солей металлов и фунгицидное средство на их основе
KR890016023A (ko) 1-디메틸카바모일-3-치환된-5-치환된-1h-1,2,4-트리아졸, 이를 함유한 조성물 및 그 사용방법
DK84785A (da) Kinatsalte af antimalariaforbindelsen mefloquin
ES2053808T3 (es) Nuevos compuestos azolicos.
RU92016560A (ru) Замещенные бензоимидазолы, фармацевтическая композиция, способ ингибирования или лечения и способ их получения и применение

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401